> ## Content Index
> Fetch the complete content index at: https://www.fdaweb.com/llms.txt
> Use this file to discover other available public pages before exploring further.

# FDA Clears Companion Medical InPen Wireless Insulin Pen
- URL: https://www.fdaweb.com/fda-clears-companion-medical-inpen-wireless-insulin-pen/
- Published: 2016-07-28T12:00:00.000Z
- Updated: 2026-09-14T21:19:10.000Z
- Author: David McFarland
- Tags: Devices, #legacy-id-D5136316

FDA has cleared a Companion Medical 510(k) for the InPen system, its wireless-enabled insulin pen and proprietary mobile application. The device includes technology to calculate and recommend optimal dosing, track history and timing of doses, monitor insulin temperature, and track and report to the health care providers, according to the company. It is cleared in the U.S. for use with Eli Lilly’s Humalog and Novo Nordisk’ Novolog rapid acting insulins. The InPen app is also cleared for Apple’s iOS operating system, and an Android version is planned for later this year.